Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-Pentixafor PET/CT for Thymoma
NCT06086327Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2023
- Primary completion
- Dec 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pentixafor in thymoma, sponsored by Peking Union Medical College Hospital. Primary endpoint: Maximum and Mean Standardized Uptake Value at 1.5 years. Status: unknown.
02
Drugs
pentixafor
03
Conditions
thymoma
Beyond the preview
Go deeper on NCT06086327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06086327.